Chapter1. TheRole ofthe Advanced Practice Nurse as Prescriber ..............................................................................4
rq rq rq rq rq rq xv rq rq xv
Chapter 2. Review of Basic Principles of Pharmacology............................................................................................5
rq rq rq rq rq rq rq
Chapter 3. Rational Drug Selection........................................................................................................................ 11
rq rq rq rq
Chapter4. Legal and Professional Issues in Prescribing .......................................................................................... 14
rq rq rq rq rq rq rq
Chapter 5. Adverse Drug Reactions ....................................................................................................................... 16
rq rq xv rq
Chapter 6. An Introduction to Pharmacogenomics ................................................................................................. 19
rq rq rq rq rq
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................. 22
rq rq rq rq
Chapter 8. Herbal Therapies .................................................................................................................................. 28
rq rq rq
Chapter 9. Cannabis .............................................................................................................................................. 31
rq rq
Chapter 10. Pharmacoeconomics .......................................................................................................................... 35
rq rq
Chapter 11. Drugs Affecting the Autonomic Nervous System ................................................................................ 38
rq rq rq rq rq rq rq
Chapter 12. Drugs Affecting the Central Nervous System ...................................................................................... 45
rq rq rq rq rq rq rq
Chapter13. Drugs Affecting the Cardiovascular and Renal Systems....................................................................... 53
rq rq rq rq rq rq rq rq
Chapter 14. Drugs Affecting the Respiratory System ............................................................................................. 61
rq rq rq rq rq rq
Chapter 15. Drugs Affecting the Hematological System ........................................................................................ 65
rq rq rq rq rq rq
Chapter16. Drugs Affecting the ImmuneSystem: Vaccines and Immunoglobulins ................................................. 69
rq rq xv rq rq rq rq rq rq
Chapter17. Drugs Affecting the Immune System: Immunomodulators .................................................................. 75
rq rq xv rq rq rq rq
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
rq rq rq rq rq rq
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesand Antidiabetic Drugs .......................... 80
rq rq rq rq rq rq rq rq
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................... 83
rq rq xv rq rq rq rq rq rq rq rq
Chapter 21. Drugs Affecting the Reproductive System .......................................................................................... 86
rq rq rq rq rq rq
Chapter 22. Drugs Affecting the Bones and Joints .................................................................................................. 92
rq rq rq rq rq rq rq
Chapter 23. Drugs Affecting the Integumentary System......................................................................................... 96
rq rq rq rq rq rq
Chapter 24. Drugs Used to Treat Bacterial Infections ............................................................................................101
rq rq rq rq xv rq rq
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ...............................................................105
rq rq rq rq xv rq rq rq rq rq
Chapter 26. Drugs Used to Treat Inflammatory Processes ....................................................................................108
rq rq rq xv xv rq rq
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .........................................................................................111
rq rq rq xv rq rq rq rq rq
Chapter 28. Anemia .............................................................................................................................................113
rq rq
Chapter 29. Anxiety and Depression.....................................................................................................................116
rq rq rq rq
Chapter 30. Attention Deficit-Hyperactivity Disorder .........................................................................................120
rq rq rq rq
Chapter 31. Asthma and Allergy ...........................................................................................................................122
rq rq rq rq
Chapter 32. Chronic Obstructive Pulmonary Disease ...........................................................................................125
rq rq rq rq rq
Chapter 33. Contraception ...................................................................................................................................127
rq rq
Chapter 34. COVID-19: Acute and Chronic..........................................................................................................130
rq rq rq rq rq
Chapter 35. Dermatological Conditions ...............................................................................................................134
rq rq rq
Chapter 36. Diabetes Management.......................................................................................................................138
rq rq rq
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease ...........................................................................146
rq rq rq rq xv rq rq
Chapter 38. Headaches ........................................................................................................................................149
rq rq
Chapter 39. Heart Failure .....................................................................................................................................153
rq rq rq
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .................................................................158
rq rq rq rq xv rq rq
Chapter 41. Menopausal Hormone Therapy .........................................................................................................161
rq rq rq rq
,Chapter 42. Hyperlipidemia .................................................................................................................................164
rq rq
Chapter 43. Hypertension ....................................................................................................................................169
rq rq
Chapter 44. Hyperthyroidism and Hypothyroidism ..............................................................................................174
rq rq rq rq
Chapter 45. Obesity .............................................................................................................................................177
rq rq
Chapter 46. Pain Management: Acute and Chronic Pain ........................................................................................181
rq rq rq rq rq rq rq
Chapter 47. Pneumonia ........................................................................................................................................185
rq rq
Chapter48. Sexually Transmitted Diseases and Vaginitis .....................................................................................187
rq rq rq xv rq xv
Chapter 49. Substance Use Disorders ...................................................................................................................190
rq rq rq rq
Chapter 50. Tuberculosis .....................................................................................................................................195
rq rq
Chapter51.UpperRespiratory Tract Infection, Pharyngitis,Sinusitis,Otitis Media, and Otitis Externa ..................197
rq rq xv rq rq xv rq xv rq
Chapter 52. Urinary Tract Infections ....................................................................................................................200
rq rq rq rq
Chapter 53. Women as Patients ............................................................................................................................203
rq rq rq rq
Chapter 54. Men as Patients ..................................................................................................................................207
rq rq xv xv
Chapter 55. Pediatric Patients...............................................................................................................................209
rq rq rq
Chapter 57. Geriatric Patients...............................................................................................................................213
rq rq rq
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e rq rq rq rq Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
rq rq xv xv rq xv rq xv rq rq
MULTIPLE CHOICE rq
1. Nurse practitioner prescriptive authority is regulated by:
rq rq rq rq rq rq
A. TheNational Councilof State Boards ofNursing
rq rq rq rq rq xv rq
B. The U.S. Drug Enforcement Administration
rq rq rq xv
C. TheState Board ofNursing for eachstate
rq rq xv rq rq rq rq
D. The State Board ofPharmacy
rq rq rq rq
ANS: r q r q C PTS: 1
2. Thebenefitsto the patient ofhavinganadvanced practiceregistered nurse (APRN)prescriber incl u
rq xv xv rq rq rq xv rq xv rq rq rq
de:
A. Nursesknowmoreabout pharmacology thanotherprescribersbecausethey takeit bot h
rq xv rq rq rq rq rq rq rq rq
in their basic nursing program and in their APRN program.
rq rq rq rq rq xv rq rq rq
B. Nurses careforthepatient from a holisticapproach and includethepatient in dec i
xv rq rq xv rq xv rq rq xv xv rq rq
sion-making regarding their care. rq rq rq
C. APRNsare less likely to prescribe narcotics and other controlledsubstances.
rq rq rq rq rq rq rq rq rq
D. APRNs are abletoprescribeindependentlyinallstates, whereas a physician’s ass i
rq xv rq rq xv rq rq
stant needs to have a physician supervising their practice.
rq rq rq rq rq rq rq rq
ANS: r q r q B PTS: 1
3. Clinical judgment in prescribing includes:
rq rq rq rq
A. Factoring in the cost to the patient ofthe medication prescribed rq rq rq rq rq rq xv rq rq rq
B. Always prescribing the newest medication available for the diseaseprocess
rq rq rq rq rq rq rq rq
C. Handing out drug samples to poor patients rq rq rq rq xv rq
D. Prescribing all generic medications to cut costs rq rq rq rq rq xv
ANS: r q r q A PTS: 1
4. The process for choosing an effective drug for a disorderincludes:
rq rq rq rq rq rq rq rq rq rq
A. Asking the patient what drug they think would work best forthem
rq rq rq rq rq rq rq rq rq rq rq
B. Consulting nationally recognized guidelines for diseasemanagement rq rq rq rq rq
C. Prescribing medications that are available as samples beforewriting a prescription rq rq xv rq rq xv rq rq rq rq
D. Following U.S. Drug Enforcement Administration guidelines forprescribing rq rq rq rq xv rq
ANS: r q r q B PTS: 1
5. Nonintentional nonadherence of drug therapy may occur due to: rq rq rq rq rq rq rq rq
A. Belief that medication does not work rq rq xv rq xv
B. Adverse drug reactions rq rq
C. Chronic conditions that require dailytherapy rq rq rq rq
D. Forgetfulness ordistraction rq
ANS: r q r q D PTS: 1